Results 141 to 150 of about 164,738 (314)
Charcot-Marie-Tooth disease (CMT) is a genetic peripheral neuropathy caused by mutations in many functionally diverse genes. The aminoacyl-tRNA synthetase (ARS) enzymes, which transfer amino acids to partner tRNAs for protein synthesis, represent the ...
Elena R. Rhymes +10 more
doaj +1 more source
ABSTRACT Background and Objectives Multiple sclerosis (MS) exhibits racially disparate rates of disease progression. Black people with MS (B‐PwMS) experience a more severe disease course than non‐Hispanic White people with MS (NHW‐PwMS). Here we investigated structural and functional connectivity as well as structure–function decoupling in the ...
Emilio Cipriano +11 more
wiley +1 more source
COMPLEX COGNITIVE DISRUPTION IN FRONTAL DEMENTIA RELATED TO MOTOR NEURON DISEASE
We describe a patient in whom motor neuron disease and frontal dementia showed concomitant development. This patient underwent a detailed and sequential neurolinguistic assessment, which indicated an alteration in language planning, language ...
PAOLA TORRE +5 more
core +1 more source
Loneliness as neurobehavioral issue in amyotrophic lateral sclerosis
Objective In elderly people loneliness represents a risk factor for dementia and may negatively impact on mental and physical health. The specific contribute of loneliness to cognitive and behavioral functioning have not yet been determined in ...
Monica Consonni +9 more
doaj +1 more source
Vestibular Patient Journey: Insights From Vestibular Disorders Association (VeDA) Registry
ABSTRACT Objective Vestibular symptoms impose a high burden of disability. Understanding real‐world diagnostic and treatment pathways can identify care gaps and guide interventions. We aimed to characterize symptom profiles, diagnostic trends, provider involvement, and treatment patterns in vestibular disorders.
Ali Rafati +10 more
wiley +1 more source
ABSTRACT Objective Cognitive decline is a disabling and variable feature of Parkinson disease (PD). While cholinergic system degeneration is linked to cognitive impairments in PD, most prior research reported cross‐sectional associations. We aimed to fill this gap by investigating whether baseline regional cerebral vesicular acetylcholine transporter ...
Taylor Brown +6 more
wiley +1 more source
Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational ...
P Talman (13420677) +13 more
core
Developmental and Epileptic Encephalopathy due to Biallelic Pathogenic Variants in PIGM
ABSTRACT Objective PIGM encodes a critical enzyme in the glycosylphosphatidylinositol (GPI)‐anchor biosynthesis pathway. While promoter‐region mutations in PIGM have been associated with a relatively mild phenotype characterized by portal vein thrombosis and absence seizures, recent evidence suggests that coding‐region mutations result in a more severe
Júlia Sala‐Coromina +11 more
wiley +1 more source
Splicing therapeutics in SMN2 and APOB
Splicing therapeutics are defined as the deliberate modification of RNA splicing to achieve therapeutic goals. Various techniques for splicing therapeutics have been described, and most of these involve the use of antisense oligonucleotide-based ...
Krainer, AR +3 more
core
肌萎缩侧索硬化医疗质量控制指标 Medical Quality Control Indicators for Amyotrophic Lateral Sclerosis
国家神经系统疾病医疗质量控制中心于2022年设立了运动神经元病(motor neuron disease,MND)质控专病组,启动了肌萎缩侧索硬化(amyotrophic lateral sclerosis,ALS)/MND医疗质量控制体系建设。通过系统调研循证医学证据和国内外指南,MND质控专病组利用德尔菲法制定了ALS医疗质量控制指标体系,从统一诊断标准,建立患者全面管理概念,规范治疗方案等方面系统完善ALS的住院诊疗质量控制过程。该ALS医疗质量控制指标体系共15个指标 ...
The Motor Neuron Disease Working Group of National Center for Healthcare Quality Management in Neurological Diseases
doaj +1 more source

